Immunogenicity of Biosimilar Therapeutics in Drug Development (Q167968)
From geokb
This cluster of papers focuses on the immunogenicity of biosimilar therapeutics, including the validation of bioanalytical methods for assessing immunogenicity, the impact of manufacturing changes on immunogenicity, and the clinical outcomes and safe
- Biosimilars
- Immunogenicity
- Bioanalytical Methods
- Therapeutic Proteins
- Dried Blood Spots
- Erythropoietin Antibodies
- Monoclonal Antibodies
- Regulatory Guidelines
- Biopharmaceuticals
- Clinical Outcomes
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity of Biosimilar Therapeutics in Drug Development |
This cluster of papers focuses on the immunogenicity of biosimilar therapeutics, including the validation of bioanalytical methods for assessing immunogenicity, the impact of manufacturing changes on immunogenicity, and the clinical outcomes and safe |
|
